NAV: 31 Oct 2024 | ₹131.05 |
Min. SIP amount | Not Supported |
Rating | 3 |
Fund size | ₹8,768.67Cr |
1Y | 3Y | 5Y | All | |
---|---|---|---|---|
Fund returns | 51.1% | 19.8% | 28.2% | 21.3% |
Category average | 57.2% | 19.9% | 28.1% | NA |
Rank with in category | 16 | 4 | 3 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 14.41% |
Divi's Laboratories Ltd. | Healthcare | Equity | 8.39% |
Lupin Ltd. | Healthcare | Equity | 8.01% |
Cipla Ltd. | Healthcare | Equity | 5.85% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 5.39% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.33% |
Ajanta Pharma Ltd. | Healthcare | Equity | 3.50% |
Vijaya Diagnostic Centre Ltd. | Healthcare | Equity | 3.31% |
Gland Pharma Ltd. | Healthcare | Equity | 3.07% |
Abbott India Ltd. | Healthcare | Equity | 2.87% |
Inclusive of GST
Exit load of 1% if redeemed within 1 month.
0.005% (from July 1st, 2020)
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Min. for 1st investment | Not Supported |
Min. for 2nd investment onwards | Not Supported |
Min. for SIP | Not Supported |